Lam Research Currently Down Nine Consecutive Days, on Track for Record Losing Streak — Data Talk
Lam Research Corporation (LRCX) is currently at $269.97, down $16.95 or 5.91%
--Would be lowest close since Sept. 17, 2026, when it closed at $269.31
--On pace for largest percent decrease since Sept. 14, 2026, when it fell 8.29%
--Currently down nine consecutive days; down 22.31% over this period
--Longest losing streak on record (Based on available data back to May 4, 1984)
--Worst nine day stretch since the nine days ending April 4, 2025, when it fell 24.23%
--Down 17.82% month-to-date
--Up 57.71% year-to-date
--Down 37.7% from its all-time closing high of $433.33 on June 30, 2026
--Up 89.62% from 52 weeks ago (Oct. 16, 2025), when it closed at $142.37
--Down 37.7% from its 52-week closing high of $433.33 on June 30, 2026
--Up 93.4% from its 52-week closing low of $139.59 on Nov. 20, 2025
--Traded as low as $267.17; lowest intraday level since Sept. 17, 2026, when it hit $266.90
--Down 6.88% at today's intraday low; largest intraday percent decrease since Sept. 14, 2026, when it fell as much as 8.38%
--Seventh worst performer in the Nasdaq 100 today
All data as of 10:23:57 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
October 15, 2026 10:46 ET (14:46 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
5 Stocks to Sell for Tax-Loss Harvesting
33 Undervalued Stocks to Buy Before the Market Shifts Again
What’s Ahead for Stocks This Quarter—and Where to Invest
Ask the Analyst: What Is the Best Source for Low-Risk Tax-Free Income?
